Article, Early Access, 2023

Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes

NEW ENGLAND JOURNAL OF MEDICINE, ISSN 0028-4793, 10.1056/NEJMoa2307563

Contributors

Lincoff, A. Michael 0000-0001-8175-2121 (Corresponding author) [1] [2] Brown-Frandsen, Kirstine [3] Colhoun, H. M. 0000-0002-8345-3288 [4] Deanfield, J. [5] [6] Emerson, Scott S. [7] [8] Esbjerg, Sille [3] Hardt-Lindberg, Soren [3] Hovingh, G. K. 0000-0002-8145-1676 [3] [9] [10] Kahn, Steven E. [7] [8] [11] [12] [13] Kushner, Robert [14] [15] Lingvay, Ildiko [16] [17] Oral, Tugce Kalayci [3] Michelsen, Marie M. [3] Plutzky, Jorge 0000-0002-7194-9876 [18] [19] [20] Tornoe, C [3] Ryan, Donna H. [21] [22] [23] SELECT Trial Investigators

Affiliations

  1. [1] Case Western Reserve Univ, Cleveland Clin Lerner Coll Med, Dept Cardiovasc Med, Cleveland Clin, Cleveland, OH USA
  2. [NORA names: United States; America, North; OECD];
  3. [2] Case Western Reserve Univ, Cleveland Clin Lerner Coll Med, Dept Cardiovasc Med, Cleveland Clin, Cleveland, OH USA
  4. [NORA names: United States; America, North; OECD];
  5. [3] NOVO Nordisk, Soborg, Denmark
  6. [NORA names: Novo Nordisk; Private Research; Denmark; Europe, EU; Nordic; OECD];
  7. [4] Univ Edinburgh, Inst Genet & Mol Med, Edinburgh, Scotland
  8. [NORA names: United Kingdom; Europe, Non-EU; OECD];
  9. [5] UCL, Natl Inst Cardiovasc Outcomes Res, London, England
  10. [NORA names: United Kingdom; Europe, Non-EU; OECD];

Abstract

Abstract not displayed. As this article is not marked as Open Access, it is unclear if we are allowed to show the abstract. Please use the link in the sidebar to view the data provider version of the article including abstract.

Data Provider: Clarivate